Cadila Healthcare receives DCGI grant for phase 3 trials of ZyCoV-D

By Nikita Chaurasia  Date: 2021-01-04

Cadila Healthcare receives DCGI grant for phase 3 trials of ZyCoV-D

Indian pharmaceutical company Cadila Healthcare Limited, commonly known as Zydus Cadila, has made it to the headlines after receiving the approval of the DCGI (Drugs Controller General of India) for the Phase 3 clinical trials of its Coronavirus vaccine ZyCoV-D.

For the uninitiated, ZyCoV-D is a plasmid DNA, which translates into viral proteins when introduced into the host cells in order to trigger a robust immune response, facilitated by the humoral and cellular arms of the human immune system.

The Phase 3 trial round will include around 30000 volunteers. Sources confirmed that the company plans on initiating the launch as well as administration of the vaccine in the first quarter of the next financial year if the trial results are in its favor.

Reportedly, ZyCoV-D was proven to be well-tolerated, safe and immunogenic in its phase-1 and phase-2 clinical trials. It is also worth mentioning that the phase-2 trial round was conducted on around 1000 volunteers and included a randomized, multi-centric, dose-escalation double-blind placebo-controlled study.

The phase-2 trials were reviewed by an independent DSMB (Data Safety Monitoring Board) and the reports of the safety outcomes were submitted to the CDSCO (Central Drugs Standard Control Organization). Zydus Cadila then called for the DCGI approval after the phase-2 trials concluded positive outcomes.

Chairman of Zydus Group, Pankaj Patel was reported saying that the DCGI approval marks a significant milestone for the company’s vaccine development program. The phase-3 trials will ascertain the efficacy of ZyCoV-D in the treatment of Covid-19, he added.

The introduction of ZyCoV-D, developed in the company's Ahmedabad-based Vaccine Technology Centre, has paved the way for the establishment of a DNA vaccine platform in India, sources claimed. This platform has proven to improve vaccine stability and hence requires lower cold chain storage.

Moreover, Zydus Cadila has reportedly employed around 300 scientists to conduct comprehensive research on the vaccine, with around 1,400 researchers working on pharmaceutical technologies, biologicals and chemical entities (NCEs).

Source credits –

https://www.business-standard.com/article/current-affairs/zydus-gets-dcgi-nod-for-conducting-phase-3-clinical-trials-of-zycov-d-121010300466_1.html

About Author

Nikita Chaurasia     aeresearch.net

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Canada limits 5G around airports over aircraft interference concerns

Canada limits 5G around airports over aircraft interference concerns

By Nikita Chaurasia

Much to the surprise of the telecom industry, the Department of Innovation, Science, and Economic Development (ISED) of Canada has reportedly decided to limit some 5G services that could possibly interfere with radio altimeters, which are crucial com...

U.S. planning to invest billions to expand COVID-19 vaccine production

U.S. planning to invest billions to expand COVID-19 vaccine production

By Nikita Chaurasia

The United States is reportedly planning to make substantial investments to improve its COVID-19 vaccine manufacturing capacity. The country intends to produce at least a billion doses by the second half of 2022. This decision is driven by the huge ...

Peloton sues rival firms iFit and Echelon for patent infringement

Peloton sues rival firms iFit and Echelon for patent infringement

By Nikita Chaurasia

U.S.-based exercise equipment and media company Peloton Interactive Inc. has reportedly filed lawsuits against its rivals Echelon Fitness and iFit, claiming that they violated patents related to its on-demand classes. Peloton stated that Echelon and...

Apple’s digital ID card plan could be funded through states, taxpayers

Apple’s digital ID card plan could be funded through states, taxpayers

By Nikita Chaurasia

Apple is reportedly working on allowing users in participating states to digitally store their state IDs  or driver’s licenses on their iPhone wallet. However, the multibillion-dollar company will partially rely on the respective states &m...

South Korea demonstrates systems for urban air mobility management

South Korea demonstrates systems for urban air mobility management

By Nikita Chaurasia

South Korea has reportedly tested methods for operating urban air mobility (UAM) vehicles, which it aims to use for taxis that will fly between downtown Seoul and major airports as early as 2025. In 2020, South Korea had announced its plan to launch...